H.C. Wainwright raises target for Calumet stock to USD 75.00
H.C. Wainwright has increased its price target for Calumet stock from USD 60.00 to USD 75.00, following the company's recent move to raise its asset-based loan commitments by USD 100 million. This financial maneuver, alongside a USD 34 million draw from a Department of Energy loan guarantee, aims to provide more working capital and support its specialty products and renewable fuels segments. Despite a revenue increase of 40.80% in the last quarter, Calumet still reported a GAAP net loss, highlighting the forward-looking nature of the analyst's optimistic target.
Calumet to Attend Barclays Annual Energy-Power Conference
Calumet, Inc. (NASDAQ: CLMT) announced its plan to attend the Barclays 40th Annual Energy-Power Conference on Thursday, September 10, 2026. During the event, Calumet will conduct one-on-one investor meetings throughout the day. The company, headquartered in Indianapolis, Indiana, specializes in manufacturing and marketing specialty branded products and renewable fuels across North America.
Calumet Inc (CLMT-Q) Stock Price and News
This article provides stock price and news information for Calumet Inc (CLMT-Q), traded on NASDAQ. It includes real-time and historical financial data, analyst ratings, and a compilation of recent news articles from various sources covering the company's performance, earnings, and strategic moves. Calumet Inc. manufactures, formulates, and markets specialty branded products and renewable fuels.
Form 4 Calumet Inc For: 29 September By Investing.com
The article is a financial news brief from Investing.com, reporting on a Form 4 filing for Calumet Inc. on September 29. It provides minimal details beyond the filing's existence and lists Calumet's stock symbol CLMT along with its current price performance. The main content is simply a headline, as is common with these types of automated financial alerts.
Form 4 Calumet Inc For: 29 September By Investing.com
This article announces the filing of Form 4 for Calumet Inc. on September 29. It provides basic stock market data, including the performance of CLMT, and lists various market indices, commodities, and stocks. The content is brief, primarily serving as a notification of the SEC filing.
Calumet: I Don't Doubt The Long-Term, Just The Current Valuation (NASDAQ:CLMT)
Calumet (CLMT) is poised to significantly increase its sustainable aviation fuel (SAF) capacity by 2028, targeting 200 million gallons. While SAF and renewable fuel growth drive the investment thesis, the company's profitability heavily relies on government credits like the 45Z. After a substantial 180% share price rally, the current valuation offers limited upside, leading to a "Hold" rating, with future gains largely dependent on the extension of expiring government policies.
These 10 energy stocks posted the biggest one-month gains as September ends
As September 2026 concludes, the energy sector has seen significant gains, with several companies posting strong one-month performances amidst broader market consolidation. The article highlights the top 10 performing energy stocks, including CVR Energy, Inc. (CVI) and Solaris Energy Infrastructure, Inc. (SEI), which led the gains despite some holding only "Hold" Quant Ratings. Many of the listed stocks, such as PBF Energy Inc. (PBF) and Valero Energy Corporation (VLO), carry "Strong Buy" Quant Ratings.
Calumet, Inc. (NASDAQ:CLMT) Receives Consensus Recommendation of "Hold" from Brokerages
Calumet, Inc. (NASDAQ:CLMT) has received a consensus "Hold" rating from seven brokerages, with an average 12-month price target of $51.75, which is below its current trading price of $53.65. Analyst actions have been mixed, with some reaffirming "buy" ratings and others maintaining "neutral" or "hold" views while raising price targets. The company recently reported quarterly revenue of $1.45 billion, but posted an adjusted loss per share that missed consensus estimates.
390,906 Calumet, Inc. $CLMT Shares Bought by State Street Corp
State Street Corp increased its holdings in Calumet, Inc. by 12.7%, acquiring an additional 390,906 shares to reach a total of 3.47 million shares valued at approximately $125 million. This purchase represents 3.95% of Calumet. Despite the increased institutional investment, analyst sentiment remains mixed with a consensus "Hold" rating, while the company reported a significant loss per share for the quarter, missing consensus estimates.
Calumet Inc (CLMT) Shares Fall 3.6% -- What GF Score of 52 Tells Investors
Calumet Inc (CLMT) shares fell 3.6% to $54.38, despite significant year-to-date and one-year increases, primarily due to being significantly overvalued according to GuruFocus' GF Value™ of $18.48. The company has a GF Score™ of 52/100, indicating average performance, with strengths in profitability and growth but major concerns regarding valuation and financial strength. Insider selling activity, without any buying, further suggests a lack of confidence in the company's future prospects.
Calumet, Inc. (CLMT) Presents at TD Cowen Annual Energy Conference - Slideshow (NASDAQ:CLMT) 2026-09-24
Calumet, Inc. (CLMT) presented a slide deck at the TD Cowen Annual Energy Conference on September 24, 2026. This article from Seeking Alpha's transcripts team highlights the availability of the presentation. The slides provide details relevant to investors interested in CLMT's presence at the conference.
Calumet stock falls 3.62 percent as financing expands
Calumet stock experienced a 3.62 percent drop, trading at USD 54.38, despite expanding its financing capacity to USD 600 million and securing a USD 34 million DOE loan draw. The company reported a significant increase in Q2 2026 revenue to USD 1.45 billion but also an adjusted loss of USD 1.09 per share. This financial movement positions Calumet with improved near-term funding flexibility for renewable fuel expansion, with investors now watching how increased borrowing capacity and completed funding translate into stronger cash generation.
How Investors Are Reacting To Calumet (CLMT) Expanded Credit Facility
Calumet (CLMT) recently expanded its asset-based loan facility to US$600 million and secured a final US$34 million draw from a Department of Energy loan guarantee for Montana Renewables. These financing moves are intended to ease near-term liquidity pressures, particularly around the MaxSAF expansion, and support Calumet's strategy of generating cash from renewable fuels and specialty products despite current losses and high leverage. Investors are now evaluating how this increased liquidity will influence Calumet's investment narrative, especially concerning its ability to achieve projected revenue and earnings growth by 2029.
Montana Renewables plans to expand SAF production to 200M gallons/year by 2028
Montana Renewables aims to significantly expand its Sustainable Aviation Fuel (SAF) production at its Great Falls facility to 200 million gallons per year by 2028. The company has completed the initial phase of its MaxSAF 150 initiative and is reconfiguring assets for a second reactor, which is expected to be operational by the end of 2026. This expansion, supported by a US$1.44 billion loan from the US Department of Energy, is projected to increase SAF output gradually from 60 million gallons to 200 million gallons annually.
Bank of America Corp DE Buys Shares of 981,353 Calumet, Inc. $CLMT
Bank of America Corp DE has acquired 981,353 shares of Calumet, Inc. (NASDAQ:CLMT) worth approximately $35.3 million, giving it a 1.12% stake in the company. Other institutional investors have also increased their positions in Calumet, bringing total institutional ownership to 34.41%. While analysts have a mixed "Hold" consensus rating and a target price of $51.75, Calumet's shares recently opened near their 52-week high, despite the company reporting an adjusted loss per share in its latest quarterly earnings.
Calumet, Inc. (NASDAQ:CLMT) Upsizes ABL to $600M; MRL Draws Final $34M DOE Loan
Calumet, Inc. (CLMT) has increased its Asset-Based Loan (ABL) commitments to $600 million, enhancing liquidity and signaling strong lender support. Simultaneously, its subsidiary, Montana Renewables (MRL), received the final $34 million from its DOE Loan Guarantee Agreement, supporting the MaxSAF project with reduced capital expenditure. These actions strengthen Calumet's financial position, providing stability for its renewable fuels initiatives.
Calumet stock hits all-time high at 58.44 USD
Calumet Inc. (CLMT) stock has reached an all-time high of 58.44 USD, marking a significant increase from its 52-week low of 17.42 USD and pushing its market capitalization to approximately 5.1 billion USD. The stock has seen a 209.94% increase over the past year, with strong year-to-date and six-month returns, though InvestingPro's analysis suggests it may be overvalued and in overbought territory. This surge follows a mixed Q2 2026 financial report where revenue beat estimates but EPS missed, alongside a credit rating upgrade by S&P Global Ratings and raised price targets from UBS and TD Cowen.
Calumet stock hits all-time high at 58.44 USD By Investing.com
Calumet Inc. stock has reached an all-time high of $58.44, trading just shy of its 52-week peak. This represents a significant 209.94% increase over the past year, with a market capitalization of approximately $5.1 billion. Despite strong performance, InvestingPro data suggests the stock may be overvalued and in overbought territory.
Calumet to Attend T.D. Cowen Energy Conference
Calumet, Inc. (NASDAQ: CLMT) announced its plan to attend the T.D. Cowen 3rd Annual Energy Conference on Thursday, September 24, where it will hold one-on-one investor meetings throughout the day. The company, headquartered in Indianapolis, Indiana, manufactures specialty branded products and renewable fuels.
BlueCrest Capital Management Ltd Buys 20,000 Shares of Calumet, Inc. $CLMT
BlueCrest Capital Management Ltd increased its stake in Calumet, Inc. (NASDAQ:CLMT) by 33.3% in the second quarter, purchasing an additional 20,000 shares to own a total of 80,000 shares valued at $2.88 million. This move is part of broader institutional interest, with other firms like BlackRock and Bank of America also adjusting their positions. Despite a consensus "Hold" rating from analysts and a recent earnings miss, the company's stock has seen a 3.3% increase.
Calumet stock hits 52-week high at 54.72 USD
Calumet Specialty Products Partners, L.P. (CLMT) stock reached a 52-week high of $54.72, with a current trading price of $53.91 and a market capitalization of $4.74 billion. The stock has seen a remarkable 205.27% increase over the past year and 171% year-to-date returns, despite InvestingPro analysis suggesting it may be overvalued. Recent news includes mixed Q2 2026 results with revenue exceeding estimates but an adjusted earnings loss, an S&P Global Ratings upgrade to 'B-', and updated price targets from UBS and TD Cowen.
Calumet, Inc. $CLMT Position Boosted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS Asset Management Americas LLC increased its stake in Calumet, Inc. ($CLMT) by 19.5% in the second quarter, now owning 155,584 shares valued at $5.6 million. Despite analysts having a "Hold" rating and a consensus price target of $51.75, Calumet shares opened at $53.91, near their 52-week high, following a 1.5% rise. The company reported significant revenue growth of 40.8% year-over-year but missed earnings expectations with a loss of $1.09 per share.
Concurrent Investment Advisors LLC Invests $2.07 Million in Calumet, Inc. $CLMT
Concurrent Investment Advisors LLC has acquired 57,380 shares of Calumet, Inc. (NASDAQ:CLMT) for approximately $2.07 million during the second quarter, representing 0.07% of the company. Institutional investors collectively hold 34.41% of Calumet, which reported a quarterly loss despite a significant revenue increase. Analyst ratings for Calumet are mixed, with a consensus "Hold" rating and an average price target of $51.75.
Calumet, Inc. (CLMT) Is Up 11.27% in One Week: What You Should Know
Calumet, Inc. (CLMT) has shown significant momentum, increasing by 11.27% in the past week and 207.64% over the last year, outperforming both its industry and the S&P 500. The company holds a Zacks Momentum Style Score of A and a Zacks Rank of #2 (Buy), driven by positive short-term price activity and upward revisions in earnings estimates. This indicates a promising outlook for the stock in the near future.
Legal & General Group Plc Invests $1.73 Million in Calumet, Inc. $CLMT
Legal & General Group Plc has invested approximately $1.73 million in Calumet, Inc. by acquiring 48,140 shares, representing a 0.06% stake in the company. Other institutional investors have also adjusted their holdings in Calumet, which collectively holds 34.41% of the stock. Despite reporting strong quarterly revenue growth, Calumet missed earnings estimates, and analyst sentiment remains mixed with a "Hold" consensus rating, though some analysts have raised their price targets.
The Manufacturers Life Insurance Company Makes New $1.07 Million Investment in Calumet, Inc. $CLMT
The Manufacturers Life Insurance Company has invested $1.07 million in Calumet, Inc. (NASDAQ:CLMT) by acquiring 29,852 shares. This investment is part of broader institutional interest, with hedge funds and institutional investors owning 34.41% of the company. Despite mixed analyst ratings and a missed earnings estimate, HC Wainwright raised its price target to $75 with a "Buy" rating, while a law-firm investigation into potential shareholder claims adds uncertainty.
Wellington Management Group LLP Cuts Position in Calumet, Inc. $CLMT
Wellington Management Group LLP reduced its stake in Calumet, Inc. (NASDAQ:CLMT) by 2.3% during the second quarter, selling 19,076 shares and retaining 811,482 shares worth approximately $29.2 million. Despite this, institutional investors collectively own 34.41% of the company. Analyst sentiment remains mixed, with a consensus "Hold" rating and an average price target of $51.75, even as Calumet reported a quarterly loss of $1.09 per share, missing estimates, but saw revenue rise 40.8% year over year.
HC Wainwright Forecasts Strong Price Appreciation for Calumet (NASDAQ:CLMT) Stock
HC Wainwright has increased its price target for Calumet (NASDAQ:CLMT) from $60 to $75, maintaining a "buy" rating and suggesting a 45.57% upside. Despite a mixed analyst sentiment with an average "hold" rating, Calumet reported a 40.8% year-over-year revenue increase to $1.45 billion, although it missed earnings expectations with a loss of $1.09 per share. Insider activity shows a director selling some shares, while institutional investors have significantly adjusted their positions in the company.
Calumet, Inc. (NASDAQ:CLMT) Receives Average Rating of "Hold" from Analysts
Analysts have assigned Calumet, Inc. (NASDAQ:CLMT) an average "Hold" rating, with a consensus 12-month price target of $48.00, despite the stock trading above this at $51.52. The company reported strong quarterly revenue of $1.45 billion, a 40.8% year-over-year increase, but missed earnings expectations with a loss of $1.09 per share. Institutional investors have a significant stake, with the California State Teachers’ Retirement System notably increasing its position by over 3,300% in the last quarter.
Calumet stock hits 52-week high at 51.51 USD
Calumet Inc.'s stock reached a 52-week high of $51.51, up 207.95% over the past year and 150% year-to-date, reflecting strong investor confidence despite being potentially overvalued according to InvestingPro. This surge follows mixed Q2 2026 results with revenue beating estimates, an S&P Global Ratings upgrade, and increased price targets from UBS and TD Cowen due to strong performance in specialty oils and renewable fuels.
Calumet (NASDAQ:CLMT) Hits New 12-Month High - Still a Buy?
Calumet (NASDAQ:CLMT) recently hit a new 52-week high of $51.57, despite having a negative price-to-earnings ratio and a consensus "Hold" rating from analysts with an average price target of $48. The company's latest quarterly revenue increased by 40.8% year-over-year to $1.45 billion, but it reported an adjusted loss of $1.09 per share, missing expectations. Institutional investors hold a significant portion of the stock, while an insider recently reduced their position.
S&P upgrades Calumet rating to B- on stronger earnings
S&P Global Ratings has upgraded Calumet Inc.'s issuer credit rating to 'B-' from 'CCC+', citing robust first-half 2026 earnings and improved credit metrics. The outlook for Calumet is stable, with the rating agency noting strong performance in specialty oils, fuel crack spreads, and renewable fuel margins. S&P expects continued strong free operating cash flow in 2027 and progress in expanding sustainable aviation fuel production.
UBS Adjusts Calumet Price Target to $47 From $26, Maintains Neutral Rating
UBS has raised its price target for Calumet, Inc. (CLMT) to $47 from $26, while maintaining a Neutral rating on the stock. This adjustment reflects an updated outlook from the analyst firm on the oil & gas refining and marketing company. The article also provides recent news and financial summaries for Calumet.
Calumet to Attend Barclays Annual Energy-Power Conference
Calumet, Inc. (NASDAQ: CLMT) announced its plan to participate in the Barclays 40th Annual Energy-Power Conference on Thursday, September 10, 2026. During the conference, Calumet will engage in one-on-one investor meetings throughout the day. The company, headquartered in Indianapolis, Indiana, specializes in manufacturing, formulating, and marketing specialty branded products and renewable fuels.
Calumet to attend Barclays Energy-Power Conference with investor meetings on Sept 10
Calumet, Inc., a manufacturer of specialty branded products and renewable fuels, announced its participation in the Barclays 40th Annual Energy-Power Conference on September 10, 2026. The company plans to hold one-on-one meetings with investors throughout the day. This engagement provides an opportunity for Calumet to showcase its North American operations and maintain strong investor relations.
Calumet Inc (CLMT) Stock Down 3.5% but Still Overvalued -- GF Sc
Calumet Inc (CLMT) saw its shares drop by 3.5% to $47.28, yet GuruFocus assesses the stock as significantly overvalued by 159.4% compared to its GF Value™ of $18.23. The company, which is currently unprofitable and cash-flow negative, has a GF Score™ of 52/100, indicating average overall performance with weak valuation and financial strength scores. Further concerns include $20.7 million in insider selling over the past year with no insider buying, suggesting a cautious sentiment among institutional investors and insiders.
Two Seas Capital LP Buys New Shares in Calumet, Inc. $CLMT
Two Seas Capital LP has acquired a significant new position in Calumet, Inc. (NASDAQ:CLMT), purchasing over 6.6 million shares valued at approximately $238.4 million, making it their third-largest holding. Despite this substantial investment, analysts maintain a "Hold" consensus rating for Calumet with an average price target of $42.75. The company recently reported a quarterly loss per share that missed estimates, even though revenue saw a considerable year-over-year increase.
Calumet (CLMT) insider logs recent stock trades
Calumet, Inc. (CLMT) Director John G. Boss reported two insider transactions involving restricted stock units. These transactions, filed on Form 4, show the acquisition of 160 and 53 restricted stock units, respectively, with a price of $0.00 each, indicating they were likely grants or awards. The filing details the vesting conditions for these units, with some vesting immediately and others vesting over time starting July 1, 2027.
Calumet (NASDAQ: CLMT) insider logs new share dealings
Calumet, Inc. (CLMT) Director Stephen P. Mawer reported two transactions involving Restricted Stock Units (RSUs) on August 20, 2026. The insider received 690 RSUs which are 100% vested, and an additional 230 RSUs that will vest 25% annually starting July 1, 2027, both valued at $0.00. These filings were made to the SEC via a Form 4, indicating no immediate cash transactions but awards of equity compensation.
Calumet (CLMT) insider reports latest stock dealings
Calumet, Inc. (CLMT) Director Amy M. Schumacher reported two transactions involving Restricted Stock Units (RSUs) in a recent Form 4 SEC filing. These transactions involve 488 RSUs and 162 RSUs, both granted with a value of $0.00, meaning they were grants or awards rather than purchases. The RSUs have specific vesting and settlement conditions, with some immediately vested and others vesting incrementally starting July 1, 2027.
one8zero8 LLC Acquires Shares of 186,020 Calumet, Inc. $CLMT
one8zero8 LLC recently acquired 186,020 shares of Calumet, Inc. (NASDAQ:CLMT) worth approximately $6.7 million, making it their 17th-largest holding. This acquisition comes as Calumet reported Q2 revenue of $1.45 billion, a 40.8% year-over-year increase, but missed earnings expectations with a loss of $1.09 per share. Analyst sentiment for Calumet remains mixed, with a "Hold" consensus and an average price target of $42.75.
Calumet stock hits 52-week high at 49.27 USD By Investing.com
Calumet Specialty Products Partners (CLMT) stock recently reached a 52-week high of $49.17 USD, pushing its market capitalization to $4.31 billion. This surge reflects a 1-year total return of 265.46% and a year-to-date gain of 143%, although InvestingPro analysis suggests the stock is currently overvalued and was not profitable in the past year, with analysts predicting profitability this year. The company reported mixed Q2 2026 results, surpassing revenue estimates with $1.44 billion but missing EPS projections with a loss of $1.09 per share, yet generated $175 million in adjusted EBITDA.
Is Calumet Inc (CLMT) Overvalued After 5.1% Rally? GF Value Says
Calumet Inc (CLMT) saw a 5.1% rally, but GuruFocus's GF Value suggests the stock is significantly overvalued at $50.81 compared to its intrinsic value of $18.23, indicating a 178.7% overvaluation. The company's GF Score of 54/100 points to mixed performance, with concerns arising from its unprofitability, negative cash flow, and substantial insider selling without any buying activity. Investors are advised to exercise caution due to these red flags.
Calumet stock hits 52-week high at 49.27 USD By Investing.com
Calumet Specialty Products Partners (CLMT) stock has reached a new 52-week high of $49.17 USD, pushing its market capitalization to $4.31 billion and demonstrating a significant 1-year return of 265.46%. While InvestingPro analysis indicates the stock is currently overvalued and the company was not profitable last year, analysts predict profitability for the current year. The company recently reported mixed Q2 2026 results with revenue beating estimates but adjusted EPS falling short, leading TD Cowen to raise its price target to $40 while maintaining a Hold rating.
Calumet stock hits 52-week high at 49.27 USD By Investing.com
Calumet Specialty Products Partners, L.P. (CLMT) stock reached a new 52-week high of $49.17 USD, pushing its market capitalization to $4.31 billion, driven by a 265.46% 1-year total return and a 143% year-to-date gain. Despite strong investor confidence and recent revenue surpassing estimates, the company reported an adjusted EPS loss of $1.09 for Q2 2026, missing anticipated profits. Analysts predict profitability for the current year, and TD Cowen raised its price target to $40 while maintaining a Hold rating.
Is Calumet’s Q2 Revenue Growth but Deeper H1 Loss Altering The Investment Case For Calumet (CLMT)?
Calumet (CLMT) reported increased Q2 2026 revenue and a narrower quarterly net loss, but its net loss for the first half of 2026 significantly widened despite higher sales, indicating ongoing profitability challenges. The investment case hinges on the company's shift towards higher-value renewables and specialty products outweighing legacy operations and debt, with debt management remaining a critical factor. While some analysts are optimistic about future revenue and earnings, the widening year-to-date losses and substantial debt present risks to investors.
Is Calumet’s Q2 Revenue Growth but Deeper H1 Loss Altering The Investment Case For Calumet (CLMT)?
Calumet, Inc. reported increased sales in Q2 2026 but a wider net loss for H1 2026, driven by ongoing profitability pressures despite revenue growth. The company's investment narrative continues to hinge on its shift to renewables and specialty products offsetting legacy operations and leverage, with debt management being a critical factor. While Q2 saw narrowed losses, the larger first-half loss highlights persistent balance sheet risks and cash generation concerns.
Russell Investments Group Ltd. Buys 30,990 Shares of Calumet, Inc. $CLMT
Russell Investments Group Ltd. increased its stake in Calumet, Inc. by 239.4% in the second quarter, purchasing an additional 30,990 shares to bring its total holding to 43,935 shares valued at $1.58 million. Despite this significant institutional investment, analyst sentiment for Calumet is mixed, with a consensus "Hold" rating and an average price target of $41.50. The company recently reported quarterly revenue of $1.45 billion, a 40.8% year-over-year increase, but missed earnings expectations with a loss of $1.09 per share.
Two Seas Capital (CLMT) discloses 7.5% Calumet stake via Two Seas Global Fund
Two Seas Capital LP, along with its affiliates, has reported a beneficial ownership of 7.5% in Calumet, Inc. (CLMT) through its Schedule 13G/A filing. This stake, totaling 6,619,708 shares of common stock, is held by Two Seas Global (Master) Fund LP. The filing indicates that Two Seas Capital and its reporting persons possess sole voting and dispositive power over these shares.
Wasserstein group (CLMT) discloses 4.6% Calumet Inc. ownership in Schedule 13G/A
Wasserstein Management L.P. and its affiliated entities have reported a beneficial ownership of 4.6% in Calumet Inc. (CLMT) common stock, as detailed in an amended Schedule 13G filing on June 30, 2026. This stake amounts to 3,964,893 shares out of 87,147,147 total shares outstanding. The ownership is primarily held through Wasserstein Master, LP and separately managed accounts, with shared voting and dispositive power among affiliated general partners and control persons, including Rajay Bagaria and Joseph Dutton.
